People | December 04, 2024
Ann-Xiaoyan Li appointed Group CFO and MD of Romaco Group
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
New research labs and process development services to enable next generation therapeutics
Dr. Muthu was last associated with Mankind Pharma
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
Subscribe To Our Newsletter & Stay Updated
